BeiGene, Ltd. (ONC) Tops Q4 EPS by 42c, provides guidance

BeiGene, Ltd. (NASDAQ: ONC) reported Q4 EPS of $1.95, $0.42 better than the analyst estimate of $1.53. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.46 billion.

GUIDANCE:

BeiGene, Ltd. sees FY2026 revenue of $6.2-6.4 billion, versus the consensus of $6.441 billion.

For earnings history and earnings-related data on BeiGene, Ltd. (ONC) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• First Majestic raises 2026 output guidance after Q2 silver, gold gains
• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance